Published in Hepatitis Weekly, December 12th, 2011
"The IFN-a resistance mechanism of the replicon cells were addressed by a complementation study that utilized the full-length plasmid clones of IFN-a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.